Singapore markets close in 3 hours 59 minutes
Straits Times Index
3,325.36 -0.92 (-0.03%) Nikkei
39,643.07 +469.92 (+1.20%) Hang Seng
18,069.75 -3.15 (-0.02%) FTSE 100
8,247.79 -33.76 (-0.41%) Bitcoin USD
61,710.86 +373.09 (+0.61%) CMC Crypto 200
1,280.80 +31.68 (+2.54%)
LivaNova PLC (LIVN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 54.45 |
| Open | 54.34 |
| Bid | 53.55 x 100 |
| Ask | 53.62 x 100 |
| Day's range | 53.39 - 54.43 |
| 52-week range | 42.75 - 64.47 |
| Volume | |
| Avg. volume | 655,214 |
| Market cap | 2.901B |
| Beta (5Y monthly) | 0.99 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.60 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 71.56 |
Business WireLivaNova to Announce Second-Quarter 2024 Results
LONDON, June 18, 2024--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call.
Simply Wall St.An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 31% Undervalued
Key Insights The projected fair value for LivaNova is US$76.63 based on 2 Stage Free Cash Flow to Equity Current share...
Business WireLivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
LONDON, June 06, 2024--LivaNova announced preliminary results for the unipolar cohort of the RECOVER study, assessing use of VNS Therapy in treatment-resistant depression.
© 2024 Yahoo. All rights reserved.